<DOC>
	<DOCNO>NCT00525616</DOCNO>
	<brief_summary>The aim study ass possible control single cycle rituximab patient bullous pemphigoid .</brief_summary>
	<brief_title>Efficiency Tolerance Rituximab ( mabth√©ra ) Bullous Pemphigoid</brief_title>
	<detailed_description>The objective study ass efficacy tolerance single cycle rituximab control bullous pemphigoid . main object : 1. ass single cycle rituximab able control patient corticosteroid-dependent bullous pemphigoid , 2. avoid use corticosteroid long time , 3. evaluate duration control disease side effect single cycle rituximab .</detailed_description>
	<mesh_term>Pemphigoid , Bullous</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>age &gt; = 18 &lt; 80 karnofsky &gt; = 50 % bullous pemphigoid clinical indication corticodependent bullous pemphigoid relapse second time contraception use female patient consent obtain patient localize bullous pemphigoid relapse ( &lt; 400cm2 ) pemphigoid pregnancy dermatosis IgA pemphigoid mucous damage pregnant woman nurse mother woman able baby without contraception clinical trial period age &lt; 18 &gt; 80 karnovsky &lt; 50 % significant disease uncontrolled disease serious antecedent allergy anaphylactic reaction human monoclonal antibody patient depletion lymphocytic treatment initial rituximab treatment unstable angina ischemic heart disease cardiac insufficiency cardiac rhythm trouble uncontrolled evolutive infection immunodepression neutrophil polynuclear blood &lt; 1.5 G/l /or platelet blood concentration &lt; 75G/l positive HIV serology positive hepatitis B / C serology concomitant immunodepressor treatment able induce depletion lymphocytic treatment consentment antecedent serious chronic recurrent infection underlie pathology able induce serious infection antecedent deep tissue infection occur previous year inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>bullous pemphigoid</keyword>
	<keyword>mabthera</keyword>
</DOC>